Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salusin-alpha and Lipid Abnormalities in Hemodialysis Patients
NCT01448174Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Oct 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in hyperlipidemia (4 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Normalization of serum LDL cholesterol at 30 weeks. Started Oct 2011; status: completed.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT01448174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448174.